Zydus Cadila to market Warfarin tablets

New Delhi, June 1 (UNI) Zydus Cadila, Ahmedabad based pharma company, today announced it has received approval from the US Food and Drug Administration (FDA) to market Warfarin tablets, an anti-coagulant drug.

The group plans to launch the product within a month's time. The branded sales of the product in 2005 was reported to be over 210 million dollars.

The drug which falls in the cardiovascular segment comes out in different strengths of 1 mg, 2 mg, 2.5 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7.5 mg and 10 mg.

The group which now has a total of 14 approvals is likely to have considerable competitive advantage in this product as it will be sourcing the API from its own USFDA approved manufacturing facility at Dabhasa.

UNI MP SBJ RK2054